E C Madu1. 1. Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN 37232-6300, USA.
Abstract
BACKGROUND: The evaluation of chest pain or suspected coronary artery disease (CAD) in morbidly obese subjects is limited by the inability of routine diagnostic techniques to adequately image these individuals. Morbidly obese subjects are therefore often inadequately treated or inappropriately treated for presumed CAD. METHODS AND RESULTS: We prospectively evaluated 23 morbidly obese patients with chest pain using transesophageal dobutamine stress echocardiography (TE-DSE). The mean (+/- SD) weight was 164 +/- 8 kg (range, 118 to 215 kg). We identified nine patients with abnormal TE-DSE findings. Five of these patients subsequently had cardiac catheterization with confirmation of CAD in the regions identified by TE-DSE. Over a follow-up period of 18 +/- 6 months, three cardiac events (non-Q-wave myocardial infarction) occurred in the same group, including two patients without confirmatory cardiac catheterization data. Thus, seven of nine patients with positive results of TE-DSE had objective confirmatory evidence of CAD. No cardiac events were observed in the group with normal TE-DSE over the same follow-up period. CONCLUSION: TE-DSE is a safe and potentially useful technique for the evaluation of suspected CAD in morbidly obese subjects.
BACKGROUND: The evaluation of chest pain or suspected coronary artery disease (CAD) in morbidly obese subjects is limited by the inability of routine diagnostic techniques to adequately image these individuals. Morbidly obese subjects are therefore often inadequately treated or inappropriately treated for presumed CAD. METHODS AND RESULTS: We prospectively evaluated 23 morbidly obesepatients with chest pain using transesophageal dobutamine stress echocardiography (TE-DSE). The mean (+/- SD) weight was 164 +/- 8 kg (range, 118 to 215 kg). We identified nine patients with abnormal TE-DSE findings. Five of these patients subsequently had cardiac catheterization with confirmation of CAD in the regions identified by TE-DSE. Over a follow-up period of 18 +/- 6 months, three cardiac events (non-Q-wave myocardial infarction) occurred in the same group, including two patients without confirmatory cardiac catheterization data. Thus, seven of nine patients with positive results of TE-DSE had objective confirmatory evidence of CAD. No cardiac events were observed in the group with normal TE-DSE over the same follow-up period. CONCLUSION:TE-DSE is a safe and potentially useful technique for the evaluation of suspected CAD in morbidly obese subjects.
Authors: W Lane Duvall; Lori B Croft; Jared S Corriel; Andrew J Einstein; Jonathan E Fisher; Pilar S Haynes; Randi K Rose; Milena J Henzlova Journal: J Nucl Cardiol Date: 2006 Mar-Apr Impact factor: 5.952
Authors: Sylvie Legault; Mario Sénéchal; Sébastien Bergeron; Marie Arsenault; Michel Tessier; Jean Guimond; Paul Poirier Journal: Cardiovasc Ultrasound Date: 2010-07-28 Impact factor: 2.062
Authors: Stamatios Lerakis; Andreas P Kalogeropoulos; Mikhael F El-Chami; Vasiliki V Georgiopoulou; Arun Abraham; Scott A Lynch; Alex J Lewis; George C Leach; Emily J Osier; Emir Veledar; Randolph P Martin Journal: Obes Surg Date: 2007-11 Impact factor: 4.129
Authors: David Gugliotti; Paul Grant; Wael Jaber; Loutfi Aboussouan; Charles Bae; Daniel Sessler; Philip Scahuer; Roop Kaw Journal: Obes Surg Date: 2007-12-08 Impact factor: 4.129
Authors: Tiffany M Powell-Wiley; Paul Poirier; Lora E Burke; Jean-Pierre Després; Penny Gordon-Larsen; Carl J Lavie; Scott A Lear; Chiadi E Ndumele; Ian J Neeland; Prashanthan Sanders; Marie-Pierre St-Onge Journal: Circulation Date: 2021-04-22 Impact factor: 29.690
Authors: Amirata Ghorbani; David Ouyang; Abubakar Abid; Bryan He; Jonathan H Chen; Robert A Harrington; David H Liang; Euan A Ashley; James Y Zou Journal: NPJ Digit Med Date: 2020-01-24